Mitral valve disease affects the small but vital valve between the two left chambers of your heart. When this valve becomes damaged or doesn’t work properly, your heart struggles to pump blood efficiently, which can lead to fatigue, breathlessness, and more serious complications if left untreated. Treatment aims to improve heart function, reduce symptoms, and prevent future problems—ranging from medications and lifestyle changes to surgical repair or innovative minimally invasive procedures.

Understanding Treatment Goals and Options for Mitral Valve Disease

When someone receives a diagnosis of mitral valve disease, the primary focus shifts immediately to preserving heart function and preventing the condition from worsening. The treatment approach depends heavily on several factors: how severe the valve problem is, whether symptoms are present, the patient’s age and overall health, and whether the disease is progressing. Some people with mild mitral valve disease may not need any treatment at all, while others with severe disease require more aggressive intervention to avoid life-threatening complications like heart failure.^[1][2]

The goal of treating mitral valve disease is not just to extend life but also to improve quality of life. This means helping patients breathe more easily, reduce fatigue, and return to daily activities that might have become difficult. Treatment strategies range from watchful waiting with regular monitoring, to medications that manage symptoms and reduce strain on the heart, to surgical procedures that repair or replace the damaged valve. In recent years, new minimally invasive techniques have emerged that offer hope for patients who cannot undergo traditional open-heart surgery.^[9][10]

Medical societies and cardiology experts have established clinical guidelines that help doctors decide when and how to treat mitral valve disease. These guidelines are based on extensive research and clinical experience. They recommend different approaches depending on whether the valve is leaking (regurgitation), narrowed (stenosis), or bulging abnormally (prolapse). The treatment landscape includes both standard therapies that have been used successfully for decades and cutting-edge approaches currently being tested in clinical trials around the world.^[14]

Standard Medical Treatment and Management

For many patients with mitral valve disease, especially those with mild to moderate symptoms, medications form the cornerstone of initial treatment. These drugs don’t fix the valve itself, but they help the heart work more efficiently and reduce the uncomfortable symptoms that can make daily life difficult. Understanding what these medications do and why they matter is important for anyone living with this condition.^[11]

Diuretics, commonly called water pills, are among the most frequently prescribed medications for mitral valve disease. These drugs help the kidneys remove excess fluid from the body, which reduces the buildup of fluid in the lungs and legs—two common problems when the mitral valve isn’t working properly. When blood backs up because of a faulty valve, fluid can leak into surrounding tissues, causing swelling and shortness of breath. Diuretics address this by promoting urination, which helps eliminate the extra fluid. Patients taking diuretics need to weigh themselves regularly, as sudden weight gain can signal fluid retention and may require medication adjustment.^[16]

Blood pressure medications are also commonly prescribed, particularly for patients with mitral regurgitation. When the valve leaks, controlling blood pressure becomes crucial because high pressure makes it harder for the heart to pump blood forward—instead, more blood leaks backward through the damaged valve. Medications called beta blockers and ACE inhibitors help reduce the workload on the heart by lowering blood pressure and making it easier for blood to flow in the right direction. These medications can slow the progression of valve disease and delay the need for surgery in some patients.^[15]

For patients who develop irregular heart rhythms—a common complication of mitral valve disease—doctors may prescribe antiarrhythmic drugs. The condition known as atrial fibrillation frequently develops when the left atrium becomes enlarged due to blood backing up from a faulty mitral valve. This irregular rhythm can cause palpitations, dizziness, and increases the risk of blood clots forming in the heart. Antiarrhythmic medications help restore and maintain a normal heart rhythm. Additionally, blood thinners may be prescribed to prevent dangerous clots from forming and traveling to the brain, where they could cause a stroke.^[7]

In some cases, particularly for patients who have had their valve replaced with a mechanical device, lifelong blood thinner therapy becomes necessary. These medications prevent clots from forming on the artificial valve surface. While effective, blood thinners require careful monitoring through regular blood tests to ensure the dose is neither too high (which increases bleeding risk) nor too low (which allows clots to form).^[15]

The duration of medication therapy varies greatly among patients. Some people with mild disease may take medications for years or even decades while being monitored regularly. Others may use medications as a temporary measure while preparing for surgery or while determining whether their condition is stable enough to avoid surgical intervention. Regular follow-up appointments, typically including echocardiograms to visualize the valve and assess heart function, help doctors decide whether the current treatment plan is working or whether adjustments are needed.^[18]

Side effects from these medications do occur and vary depending on the specific drug. Diuretics can cause frequent urination, which some patients find disruptive, and they may lead to electrolyte imbalances requiring monitoring. Beta blockers can cause fatigue, dizziness, or cold hands and feet. Blood thinners carry the risk of bleeding, which means patients need to be cautious about falls and injuries. ACE inhibitors may cause a persistent dry cough in some people. Healthcare providers work closely with patients to minimize side effects while maintaining effective treatment.^[16]

Surgical Treatment: Repair and Replacement

When medications alone cannot adequately manage symptoms or when the valve damage becomes severe enough to threaten heart function, surgery becomes the recommended option. Surgical treatment for mitral valve disease has evolved significantly over the decades, with repair techniques now preferred over replacement whenever possible. Understanding the difference between these approaches helps patients make informed decisions about their care.^[3]

Mitral valve repair represents the gold standard for treating many cases of mitral regurgitation, particularly when caused by degenerative changes or prolapse. During repair surgery, the surgeon works to preserve the patient’s own valve while fixing the problem. This might involve reshaping the valve leaflets, shortening stretched support structures called chordae tendineae, or implanting a ring around the valve opening to help it close more tightly—a technique called annuloplasty. The advantage of repair over replacement is significant: patients who keep their own valve generally have better long-term outcomes, lower risk of infection, and in many cases, don’t need lifelong blood thinners.^[12][14]

More than 50 percent of mitral valve procedures in specialized centers are now repairs rather than replacements, reflecting growing expertise in these techniques and better outcomes for patients. Successful repair depends greatly on the surgeon’s experience and skill, as well as the specific type of valve damage present. Some complex cases, particularly those involving extensive calcification or multiple damaged areas, may not be suitable for repair.^[14]

When repair isn’t possible or when the valve is too damaged to fix, mitral valve replacement becomes necessary. This involves removing the diseased valve and implanting an artificial one. Patients can choose between two types of replacement valves: mechanical valves made from durable materials like metal and carbon, or biological valves made from animal tissue (usually from pigs or cows) or human donor tissue. Mechanical valves last longer—potentially a lifetime—but require patients to take blood thinners permanently. Biological valves don’t require long-term blood thinners but typically need replacement after 10 to 20 years as they gradually wear out.^[5]

The choice between mechanical and biological valves involves weighing several factors: the patient’s age, lifestyle, willingness to take blood thinners, and personal preferences. Younger patients often receive mechanical valves to avoid multiple replacement surgeries over their lifetime, while older patients may prefer biological valves to avoid blood thinners and their associated bleeding risks. This decision is made through careful discussion between the patient and their cardiac surgery team.^[12]

Traditional mitral valve surgery requires opening the chest through the breastbone—a procedure called a sternotomy—and temporarily stopping the heart while a heart-lung machine takes over its function. While highly effective, this approach involves significant trauma to the body and a recovery period of several weeks to months. In recent years, minimally invasive surgical techniques have been developed that achieve the same results through much smaller incisions. Some surgeons now use robotic assistance to perform delicate valve repairs through tiny openings between the ribs, resulting in less pain, shorter hospital stays, and faster recovery.^[3][14]

Recovery from mitral valve surgery varies depending on the approach used and the patient’s overall health. Traditional open-heart surgery typically requires a hospital stay of five to seven days, followed by several weeks of restricted activity. Patients gradually return to normal activities over two to three months. Cardiac rehabilitation programs help speed recovery through supervised exercise and education. Minimally invasive approaches often allow patients to leave the hospital sooner and return to activities more quickly. Regular follow-up care including echocardiograms remains essential to monitor the repaired or replaced valve over time.^[22]

Treatment in Clinical Trials: New Approaches and Innovations

For patients who are considered too high-risk for traditional surgery—perhaps because of advanced age, severe heart failure, or other serious medical conditions—a revolutionary minimally invasive technique has emerged that doesn’t require opening the chest at all. This procedure, known as transcatheter edge-to-edge repair or TEER, uses a device called the MitraClip to improve how the mitral valve closes.^[13]

The MitraClip procedure represents a significant breakthrough in interventional cardiology. Rather than making large incisions, doctors access the heart through a vein in the leg. Using advanced imaging technology to guide their work, they thread a thin tube called a catheter up through the blood vessels to the heart. The catheter carries a small clip that is then carefully positioned on the mitral valve. The clip grasps the two valve leaflets and holds them together, creating a more effective seal that reduces the backward flow of blood. Think of it like using a clip to partially close a curtain that won’t close properly on its own—the opening becomes smaller and functions better.^[13]

This transcatheter approach has been rigorously tested in clinical trials, most notably the EVEREST II trial, a large randomized study that compared MitraClip therapy directly to traditional surgery. The trial found that the MitraClip procedure was safer than surgery, with fewer complications and a much shorter recovery time—many patients go home within 48 hours. However, it was somewhat less effective at completely eliminating valve leakage compared to surgical repair. The benefit-risk profile makes MitraClip particularly valuable for elderly patients or those with multiple health problems who might not survive traditional surgery. For these high-risk patients, MitraClip offers a way to reduce symptoms, improve quality of life, and potentially extend survival without the trauma of open-heart surgery.^[14]

The MitraClip device has received regulatory approval in many countries and is now used in specialized cardiac centers across the United States, Europe, and other regions. The procedure requires significant expertise—interventional cardiologists and imaging specialists work together in specially equipped catheterization laboratories. Not every patient with mitral regurgitation qualifies for this procedure; careful evaluation by a multidisciplinary team determines whether the valve anatomy is suitable and whether the patient is truly at high risk for surgery.^[13][15]

Beyond the MitraClip, researchers are actively developing and testing other transcatheter approaches for mitral valve disease. Some experimental devices aim to replace the entire mitral valve through a catheter, similar to how the transcatheter aortic valve replacement (TAVR) procedure has revolutionized treatment for aortic stenosis. These investigational mitral valve replacement devices face unique challenges because the mitral valve has a more complex shape and location than the aortic valve, but early clinical trials are showing promise.^[12]

Another area of active research involves devices that reshape the mitral valve annulus—the ring of tissue that surrounds the valve—to improve how the valve closes. These systems work by placing a special device in the vein that runs alongside the heart (the coronary sinus), which applies gentle pressure to reshape the valve opening from outside. Several such devices are currently in various phases of clinical testing in specialized centers around the world.^[15]

Clinical trials for mitral valve disease typically progress through three phases. Phase I trials focus primarily on safety—researchers want to ensure that a new device or technique doesn’t cause unacceptable harm. These studies involve small numbers of carefully selected patients. Phase II trials expand to larger patient groups and begin assessing whether the treatment actually works—does it reduce symptoms? Does it improve valve function as measured by echocardiography? Phase III trials are large comparative studies that test the new treatment against the current standard of care, like the EVEREST II trial did for MitraClip. Only after a therapy successfully passes through all these phases does it become eligible for regulatory approval and widespread clinical use.^[14]

Eligibility for clinical trials varies depending on the specific study, but generally includes patients with moderate to severe mitral valve disease who have symptoms despite medical treatment. Many trials specifically seek patients who are at high surgical risk, as these individuals have the greatest need for less invasive alternatives. Patients interested in clinical trial participation can ask their cardiologist about available studies or search clinical trial registries to find trials recruiting in their area.^[7]

Most common treatment methods

• Medications
  • Diuretics (water pills) to remove excess fluid from the body and reduce swelling in the lungs and legs
  • Beta blockers and ACE inhibitors to lower blood pressure and reduce the heart’s workload
  • Antiarrhythmic drugs to control irregular heart rhythms like atrial fibrillation
  • Blood thinners to prevent clot formation, particularly important for patients with mechanical valve replacements
• Surgical valve repair
  • Annuloplasty—implanting a ring around the valve to help it close more tightly
  • Reshaping or trimming valve leaflets to improve closure
  • Repairing or shortening stretched support structures (chordae tendineae)
  • Minimally invasive and robotic-assisted surgical techniques through small incisions
• Surgical valve replacement
  • Mechanical valve replacement using durable metal and carbon materials that last a lifetime but require permanent blood thinners
  • Biological valve replacement using animal or human donor tissue that doesn’t require long-term blood thinners but needs replacement after 10-20 years
  • Traditional open-heart surgery through the breastbone (sternotomy)
• Transcatheter procedures
  • MitraClip therapy—a minimally invasive catheter-based procedure that clips the valve leaflets together to reduce leakage
  • Transcatheter valve replacement procedures currently in clinical trials for high-risk patients
  • Annulus reshaping devices delivered through catheters to improve valve closure
• Lifestyle modifications
  • Reducing salt intake to prevent fluid retention
  • Maintaining a healthy diet rich in fruits and vegetables
  • Regular moderate exercise to maintain cardiovascular fitness
  • Controlling blood pressure through diet, exercise, and medication
  • Quitting smoking to reduce cardiovascular risk
  • Regular dental care to prevent infections that could affect the heart valve

Managing Daily Life with Mitral Valve Disease

Living with mitral valve disease requires some adjustments, but many people maintain active, fulfilling lives with proper management. Perhaps the most important aspect of living with this condition is staying vigilant about symptoms and maintaining regular communication with your healthcare team. Changes in symptoms often signal that the disease is progressing or that treatment needs adjustment. Sudden increases in shortness of breath, new chest pain, dizziness, or rapid heartbeat should never be ignored—these warrant immediate medical attention.^[16]

Daily weight monitoring is particularly important for patients with mitral regurgitation. Weighing yourself at the same time each morning—after using the bathroom but before breakfast—helps detect fluid retention early. A weight gain of two to three pounds overnight or five pounds in a week suggests that fluid is accumulating, which may mean your diuretic dose needs adjustment. This simple habit can help prevent hospital admissions for worsening heart failure.^[16][21]

Dietary modifications play a significant role in managing symptoms. Reducing sodium intake helps prevent fluid retention—the sodium in food acts like a sponge, trapping water inside your body. While avoiding the salt shaker is a good start, most dietary sodium comes from processed foods and restaurant meals. Reading nutrition labels and choosing fresh, unprocessed foods makes a substantial difference. Eating a heart-healthy diet rich in fruits, vegetables, whole grains, and lean proteins supports overall cardiovascular health.^[16][17]

Physical activity is generally encouraged, not discouraged, for people with mitral valve disease. While some patients worry that exercise might be dangerous, staying active actually helps maintain muscle strength, improves overall cardiovascular fitness, and enhances quality of life. The key is listening to your body and not pushing past your limits. Walking, swimming, and cycling are often good choices. If you develop symptoms during exercise—particularly chest pain or severe shortness of breath—stop the activity and consult your doctor. For patients with severe valve disease or those who have had surgery, cardiac rehabilitation programs provide supervised, safe exercise under professional guidance.^[16][17]

Dental health deserves special attention for anyone with heart valve disease. Infections of the heart valves, called endocarditis, can occur when bacteria from the mouth enter the bloodstream during dental procedures. While current guidelines no longer recommend routine antibiotics before dental work for most valve disease patients, those who have had valve replacements may need preventive antibiotics before certain dental procedures. Maintaining excellent oral hygiene through regular brushing, flossing, and dental check-ups reduces infection risk.^[17][20]

Smoking cessation is crucial for anyone with cardiovascular disease. Tobacco smoke damages blood vessels, accelerates atherosclerosis, and worsens heart function. For patients with mitral valve disease, quitting smoking can slow disease progression and improve overall cardiovascular health. Many resources exist to help people quit, including medications, counseling programs, and support groups.^[17][20]

Regular follow-up appointments with your cardiologist remain essential throughout your life with mitral valve disease. These visits typically include physical examinations, echocardiograms to assess valve function, and discussions about symptoms and medications. The frequency of follow-up depends on disease severity—patients with mild disease might be seen annually, while those with moderate to severe disease or those who have had procedures may need more frequent monitoring. These appointments allow your care team to detect changes early and adjust treatment before serious complications develop.^[18][19]